Product Information
DROXIDOPA 300 MG CAPSULE is a generic product labeled by Slate Run Pharmaceuticals LLC, priced at $2.2477 per EA under NDC 70436014206. Its NADAC has been published 100 times since Jun 21, 2023.
Strength
300 mg/1
Manufacturer
Slate Run Pharmaceuticals LLCNDC
70436014206
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
4/23/2025
Active Ingredients
DROXIDOPAApproval Type
Generic (ANDA)
FDA Application
ANDA215265On Market Since
11/10/2021
Pharmacological Classes
Price Statistics
The NADAC for DROXIDOPA 300 MG CAPSULE has been published 100 times since Jun 21, 2023, and over the history we have for it it has declined 12.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.2477 per EA |
|---|---|
| All-time high | $3.0478 (Nov 13, 2024) |
| All-time low | $2.2477 (Apr 23, 2025) |
| Median price | $2.5551 |
| Average price | $2.6407 |
| Largest weekly change | +12.0% (Aug 21, 2024) |
| Weeks tracked | 100 |
| Tracking since | Jun 21, 2023 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DROXIDOPA 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DROXIDOPA 300 MG CAPSULE, manufactured by Slate Run Pharmaceuticals LLC, is $2.2477 per EA (NDC 70436014206), effective May 14, 2025.
How has the price of DROXIDOPA 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DROXIDOPA 300 MG CAPSULE has declined 12.0%. It has been tracked across 100 weekly CMS publications since Jun 21, 2023.
What are the highest and lowest recorded NADAC prices for DROXIDOPA 300 MG CAPSULE?
Since Jun 21, 2023, the NADAC for DROXIDOPA 300 MG CAPSULE has ranged from a low of $2.2477 (Apr 23, 2025) to a high of $3.0478 (Nov 13, 2024), with a median of $2.5551 per EA.
Are there cheaper alternatives to DROXIDOPA 300 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as DROXIDOPA 300 MG CAPSULE, but none are currently priced below it.
Who manufactures DROXIDOPA 300 MG CAPSULE?
DROXIDOPA 300 MG CAPSULE (NDC 70436014206) is labeled by Slate Run Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification